Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2024

Phaxiam Therapeutics S.A.
Phaxiam Therapeutics S.A.

In This Article:


Article 223-16 of general regulation of French Autorité des Marchés Financiers


Listing market: Euronext Paris (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM)
Website : www.phaxiam.com

Date

Total of shares composing the share capital

Total of brut (1) voting rights



Total of net (2) voting rights

December 31, 2023

6 075 105

6 226 982

6 226 733

January 31, 2024

6 075 105

6 227 002

6 226 753

February 29, 2024

6 075 105

6 226 951

6 226 702

March 29, 2024

6 075 105

6 226 938

6 226 689

April 30, 2024

6 075 105

6 226 932

6 226 683

(1)   Gross voting rights number (or ? theoretical ? voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2)   Without treasury shares.


Attachment